In this review article, the author discusses the use of tyrosine kinase inhibitors in the management of patients with gastrointestinal stromal tumors.
Scott H. Okuno, MD
Advertisement
Articles by Scott H. Okuno, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
2
Epcoritamab Misses Sole US Primary End Point of Overall Survival in R/R DLBCL
3
Teclistamab Plus Talquetamab Yields Significant Survival Benefits in Earlier-Line R/R Myeloma
4
The OncFive: Top Oncology Articles for the Week of 7/19
5